Cargando…
Effect of Statin Intensity on the Progression of Cardiac Allograft Vasculopathy
Background: In the non-transplant population, hyperlipidaemia has shifted from targeting LDL goals to statin intensity-based treatment. It is unknown whether this strategy is also beneficial in cardiac transplantation. Methods: This single-centre retrospective study evaluated the effect of statin us...
Autores principales: | Ellimuttil, Tracey M, Harrison, Kimberly, Rollins, Allman T, Feurer, Irene D, Rega, Scott A, Gray, Jennifer, Menachem, Jonathan N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609416/ https://www.ncbi.nlm.nih.gov/pubmed/34950505 http://dx.doi.org/10.15420/cfr.2021.07 |
Ejemplares similares
-
Risk factors of cardiac allograft vasculopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015) -
Early Cardiac Allograft Vasculopathy: Are the Viruses to Blame?
por: Aggarwal, Ashim, et al.
Publicado: (2012) -
Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis
por: Skorić, Boško, et al.
Publicado: (2014) -
Coronary CTA for Surveillance of Cardiac Allograft Vasculopathy
por: Shah, Nishant R., et al.
Publicado: (2018) -
The role of everolimus in treatment of cardiac allograft vasculopathy
por: Watanabe, Tetsu
Publicado: (2013)